SLC46A1 Protein, Human (HEK293, His, MBP, FLAG)

The SLC46A1 protein is a proton-coupled folate symporter that utilizes the H(+) gradient in the proximal jejunum to drive folate absorption. It transports folate from the blood to the cerebrospinal fluid and exhibits alternating outward- and inward-open conformational states at acidic pH. SLC46A1 Protein, Human (HEK293, His, MBP, FLAG) is the recombinant human-derived SLC46A1 protein, expressed by HEK293 , with N-MBP, C-Flag, N-8*His labeled tag.

The SLC46A1 protein, a proton-coupled folate symporter, plays a pivotal role in mediating folate absorption by utilizing an H(+) gradient as the driving force. Operating primarily at the brush-border membrane of the proximal jejunum, it facilitates the intestinal absorption of folates and contributes to folate transport from blood to cerebrospinal fluid across the choroid plexus. Functioning at acidic pH, the protein undergoes alternate outward- and inward-open conformational states. Protonation of residues in the outward-open state primes the protein for transport, while binding of folate triggers the closure of the extracellular gate, leading to the inward-open state and the release of protons and folate. Additionally, SLC46A1 demonstrates versatility by transporting antifolate drugs like methotrexate and pemetrexed, widely used in cancer and autoimmune disease treatments. Moreover, it acts as a lower-affinity, pH-independent heme carrier protein, playing a crucial role in heme trafficking and increasing intracellular iron content in various tissues, including the retina, retinal pigment epithelium, hippocampal neurons, hepatocytes, and renal epithelial cells. Notably, there exists an inactive isoform of the protein that cannot mediate proton-coupled folate transport.

Human

HEK293

N-8*His;C-Flag;N-MBP

Q96NT5 (E2-P459)

113235

Partial

EGSASPPEKPRARPAAAVLCRGPVEPLVFLANFALVLQGPLTTQYLWHRFSADLGYNGTRQRGGCSNRSADPTMQEVETLTSHWTLYMNVGGFLVGLFSSTLLGAWSDSVGRRPLLVLASLGLLLQALVSVFVVQLQLHVGYFVLGRILCALLGDFGGLLAASFASVADVSSSRSRTFRMALLEASIGVAGMLASLLGGHWLRAQGYANPFWLALALLIAMTLYAAFCFGETLKEPKSTRLFTFRHHRSIVQLYVAPAPEKSRKHLALYSLAIFVVITVHFGAQDILTLYELSTPLCWDSKLIGYGSAAQHLPYLTSLLALKLLQYCLADAWVAEIGLAFNILGMVVFAFATITPLMFTGYGLLFLSLVITPVIRAKLSKLVRETEQGALFSAVACVNSLAMLTASGIFNSLYPATLNFMKGFPFLLGAGLLLIPAVLIGMLEKADPHLEFQQFPQSP

≥ 90%, as determined by reducing SDS-PAGE.

<1 EU/μg, determined by LAL method.